Sulfonyldihydroimidazopyridinone compounds as...

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

10896832

ABSTRACT:
The present invention provides a compound of formula I and the use thereof in the therapeutic treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor

REFERENCES:
patent: 4144341 (1979-03-01), Clark et al.
patent: 5288749 (1994-02-01), Meyer et al.
patent: 5585394 (1996-12-01), Di Malta et al.
patent: 6699880 (2004-03-01), Yamakawa et al.
patent: 100 12 401 (2000-03-01), None
patent: 0778277 (1997-06-01), None
Gil'manov et al. STN Accession No. 146:162986; (CAS React); Abstract of Conference,Metodicheskoi Konferentsii, Kazan, Russian Federation Dec. 22-24, 2004, 304-307.
Yao et. al. Heterocycles (2005), 65(9), 2071-2081, pp. 2074, 2077.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Sulfonyldihydroimidazopyridinone compounds as... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sulfonyldihydroimidazopyridinone compounds as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonyldihydroimidazopyridinone compounds as... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3858016

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.